Medical News

RSS

Study suggests sensitive children are more likely to do well when raised in supportive environments

Children who are especially reactive to stress are more vulnerable to adversity and have more behavior and health problems than their peers. But a new longitudinal study suggests that highly reactive children are also more likely to do well when they're raised in supportive environments.

5 Feb 2010

Top-line results from Optimer Pharmaceuticals' second fidaxomicin Phase 3 trial in CDI patients

Optimer Pharmaceuticals, Inc. today announced positive top-line results from the second of two pivotal Phase 3 trials evaluating the safety and efficacy of fidaxomicin (OPT-80) in patients with Clostridium difficile Infection (CDI). This study was conducted in approximately 100 clinical sites throughout North America and Europe. The Company plans to use data from this study to support submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the second half of 2010.

5 Feb 2010

International Stem Cell opens new cell production facility in Oceanside, California

International Stem Cell Corporation, www.internationalstemcell.com, announced today that its new cell production facility has passed final building inspection, which will enable development and manufacturing of the company and its partners’ clinical-grade stem cell products.

5 Feb 2010

Ascension Health, American Well launch ‘Online Care’ services to increase access to quality healthcare

As part of its efforts to improve the healthcare experience of those it serves and better meet their needs throughout their lives across the entire healthcare continuum, Ascension Health has reached an agreement with American Well™ Inc. to bring Online Care services to communities served by Ascension Health's local Health Ministries.

5 Feb 2010

Oxford Finance Corporation announces $25M credit facility to EUSA Pharma

Oxford Finance Corporation today announced that it is the agent and primary lender for a $25 million credit facility provided to EUSA Pharma. MidCap Financial and Silicon Valley Bank are co-lenders in the transaction.

5 Feb 2010

Attempt by Idaho lawmakers to opt out of federal health care reform could prove disastrous for the state

An attempt by Idaho lawmakers to opt out of federal health care reform could prove disastrous for the state -- resulting in the loss of over a billion federal dollars for Idaho and thousands of jobs in the state.

5 Feb 2010

New research reveals flying bats apply the laws of sonar physics to locate objects in the dark

The best way to track a moving object with a flashlight might be to aim it to one side, catching the object in the edge of the beam rather than the center. New research at the Weizmann Institute of Science reveals that bats, which 'see' with beams of sound waves, skew their beams off-center when they want to locate an object. The research, which recently appeared in Science, shows that this strategy is the most efficient for locating objects.

5 Feb 2010

Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone payment

Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. (“Zogenix”) based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.

5 Feb 2010

Study finds high levels of depression among children abused in the first five years of their lives

Although children can be depressed for many reasons, new evidence suggests that there are physiological differences among depressed children based on their experiences of abuse before age 5. Early abuse may be especially damaging due to the very young age at which it occurs.

5 Feb 2010

New class of compound could become effective antidepressant with minimal side effects

Chemists at Oregon State University have discovered and synthesized a new compound that in laboratory and animal tests appears to be similar to, but may have advantages over one of the most important antidepressant medications in the world.

5 Feb 2010

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

AMERICAN SHARED HOSPITAL SERVICES, a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that it has entered into a contract to supply a Leksell Gamma Knife® PerfexionTM system to Methodist Hospital in San Antonio, Texas. This new Perfexion system, the eighth placed by AMS to date, will replace an existing Gamma Knife supplied by AMS and is expected to begin treating patients later this year.

5 Feb 2010

Exposure to ecstasy or cocaine during adolescence could lead to drug addiction

Exposure to ecstasy or cocaine during adolescence increases the "reinforcing effects" that make people vulnerable to developing an addiction. This is the main conclusion of a research team from the University of Valencia (UV), which has shown for the first time how these changes persist into adulthood.

5 Feb 2010

Early stage trial finds malaria vaccine effectively protected young children, study says

An experimental vaccine was found to effectively protect young children from malaria in Mali, Reuters reports. According to the news service, "The vaccine, which uses an immune system booster called an adjuvant from British drugmaker GlaxoSmithKline, targets the malaria parasite as it is actively infecting red blood cells and causing fever and illness" (Steenhuysen, 2/3).

5 Feb 2010

iPSC technology for identifying agents that reprogram human somatic cells receives Notice of Allowance

Fate Therapeutics, Inc. received a Notice of Allowance from the United States Patent and Trademark Office for U.S. Patent Application Number 10/997,146 entitled "Methods for Reprogramming Somatic Cells." Upon issuance, the patent will cover foundational induced pluripotent stem cell (iPSC) technology for identifying agents that enable the reprogramming of human somatic cells, including pluripotency genes, small molecules and biologics.

5 Feb 2010

Prehistoric data suggests link between tooth enamel defects and early mortality

Ancient human teeth are telling secrets that may relate to modern-day health: Some stressful events that occurred early in development are linked to shorter life spans.

5 Feb 2010

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

ARUP Laboratories announced the release of three groundbreaking tools, downstream cost calculators, to its Suite of Utilization Management Services.

5 Feb 2010

BioClinica signs three-year, multi-million dollar deal with Cephalon

BioClinica, Inc., a leading global provider of clinical trial services, has signed a three-year, multi-million dollar deal with Cephalon, Inc. for clinical trial technology and support services.

From Clario 5 Feb 2010

BioMarin announces update on BMN 110 Phase I/II trial for Morquio A Syndrome

BioMarin Pharmaceutical Inc. today announced an update on the Phase I/II trial for BMN 110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. Preliminary clinical data from the first 24 weeks of the study (12 weeks at 0.1mg/kg and 12 weeks at 1.0 mg/kg) have been evaluated, and BioMarin plans to announce top-line results for the full 36-week study after completion of dosing at 2.0 mg/kg in the second quarter of 2010.

5 Feb 2010

ARMC selects HMS to provide hospital information system applications for its general acute hospital

Arizona Regional Medical Center (ARMC) has selected Healthcare Management Systems, Inc.® (HMS) to provide hospital information system applications for its general acute hospital, located in Mesa, Ariz.

5 Feb 2010

LDDI releases biomonitoring report on environmental neurotoxins in health affected community

The Learning and Developmental Disabilities Initiative (LDDI) today released the first-ever biomonitoring report identifying toxic chemical pollution in people from the learning and developmental disability community.

5 Feb 2010

Medical News

Study suggests sensitive children are more likely to do well when raised in supportive environments

Top-line results from Optimer Pharmaceuticals' second fidaxomicin Phase 3 trial in CDI patients

International Stem Cell opens new cell production facility in Oceanside, California

Ascension Health, American Well launch ‘Online Care’ services to increase access to quality healthcare

Oxford Finance Corporation announces $25M credit facility to EUSA Pharma

Attempt by Idaho lawmakers to opt out of federal health care reform could prove disastrous for the state

New research reveals flying bats apply the laws of sonar physics to locate objects in the dark

Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone payment

Study finds high levels of depression among children abused in the first five years of their lives

New class of compound could become effective antidepressant with minimal side effects

San Antonio Methodist Hospital upgrades to Leksell Gamma Knife Perfexion system

Exposure to ecstasy or cocaine during adolescence could lead to drug addiction

Early stage trial finds malaria vaccine effectively protected young children, study says

iPSC technology for identifying agents that reprogram human somatic cells receives Notice of Allowance

Prehistoric data suggests link between tooth enamel defects and early mortality

ARUP Laboratories adds three downstream cost calculators to its Suite of Utilization Management Services

BioClinica signs three-year, multi-million dollar deal with Cephalon

BioMarin announces update on BMN 110 Phase I/II trial for Morquio A Syndrome

ARMC selects HMS to provide hospital information system applications for its general acute hospital

LDDI releases biomonitoring report on environmental neurotoxins in health affected community

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News